RepRegen™, the ‘smart biomaterials’ company that is a spin-out from Imperial Innovations plc, announced today that it has been recognized as one of the UK’s ‘Top 50 University Spin-out Companies’ by Britain’s largest-selling1 daily newspaper, The Daily Telegraph, which “has begun tracking the progress of 50 highly promising university spin-outs to show the breadth of cutting-edge technology emerging from Britain's universities.”
BioStorage Technologies, a global leader in sample management and cold-chain logistics for the pharma and biotech industries, has recently been approved as a Certified Cargo Screening Facility (CCSF) by the U.S. Transpor...
Rodocanachi Capital Inc. ("Rodocanachi") (TSX VENTURE:ROD.P), a capital pool company (as defined in Policy 2.4 (the "CPC Policy") of the TSX Venture Exchange (the "Exchange")), is pleased to...
In a counter-intuitive finding, scientists at New York University (NYU) and Polytechnic Institute of New York University (NYU-Poly) report that the foam used in helmets and other body armor indeed absorbs damage when com...
Zeus, Inc., an international leader in material science and the manufacture of fluoropolymer tubing, announces that its entire Biomaterials Facility, including synthesis and processing, is now ISO Class 7 certified.
...
BioServe and the Windber Research Institute (WRI) announced today the formation of an exclusive strategic alliance that will help put high quality tissue samples into the hands of biomedical researchers worldwide.
...
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced the Company has entered into a multi-year supply agreement with a global medical device company.
China Ruitai International Holdings Co., Ltd. ("China Ruitai" or the "Company") (OTC Bulletin Board: CRUI), a manufacturer of cellulose ether additives for use in the production of pharmaceuticals, construction mate...
Brookhaven Science Associates, the company that manages the U.S. Department of Energy’s Brookhaven National Laboratory, and Biosurface Engineering Technologies, Inc. (BioSET) of Rockville, Maryland, have been issued a U.S. patent for an improved second-generation technology for designing synthetic peptides that are important for tissue regeneration.
Catalyst Pharmaceutical Partners, Inc. (NasdaqCM: CPRX) today announced that the European Patent Office (EPO) granted to Brookhaven Science Associates/Brookhaven National Laboratory (Brookhaven) a European patent fo...
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.